JPWO2022256680A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022256680A5 JPWO2022256680A5 JP2024518956A JP2024518956A JPWO2022256680A5 JP WO2022256680 A5 JPWO2022256680 A5 JP WO2022256680A5 JP 2024518956 A JP2024518956 A JP 2024518956A JP 2024518956 A JP2024518956 A JP 2024518956A JP WO2022256680 A5 JPWO2022256680 A5 JP WO2022256680A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- compound
- alkyl
- tumor
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163196744P | 2021-06-04 | 2021-06-04 | |
| US63/196,744 | 2021-06-04 | ||
| PCT/US2022/032203 WO2022256680A1 (en) | 2021-06-04 | 2022-06-03 | Pyridopyrimidine derivatives useful as wee1 kinase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024522304A JP2024522304A (ja) | 2024-06-13 |
| JP2024522304A5 JP2024522304A5 (https=) | 2025-06-10 |
| JPWO2022256680A5 true JPWO2022256680A5 (https=) | 2025-06-10 |
Family
ID=82321319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024518956A Pending JP2024522304A (ja) | 2021-06-04 | 2022-06-03 | Ｗｅｅ１キナーゼ阻害剤として有用なピリドピリミジン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240254123A1 (https=) |
| EP (1) | EP4347592A1 (https=) |
| JP (1) | JP2024522304A (https=) |
| KR (1) | KR20240044409A (https=) |
| CN (1) | CN117794932A (https=) |
| AU (2) | AU2022287033B2 (https=) |
| CA (1) | CA3225152A1 (https=) |
| IL (1) | IL309037A (https=) |
| MX (1) | MX2023014466A (https=) |
| WO (1) | WO2022256680A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL315441A (en) | 2022-03-07 | 2024-11-01 | Debiopharm Int Sa | Treatment methods for small cell lung cancer |
| IL326854A (en) | 2023-09-14 | 2026-04-01 | Debiopharm Int Sa | Combination of WEE1 inhibitor and PKMYT1 inhibitor |
| CN120189510A (zh) * | 2023-12-21 | 2025-06-24 | 北京哲源科技有限责任公司 | 一种并环化合物的应用 |
| TW202541810A (zh) | 2023-12-22 | 2025-11-01 | 瑞士商德彪製藥國際公司 | 治療實體腫瘤之方法 |
| WO2025186213A1 (en) | 2024-03-04 | 2025-09-12 | Debiopharm International S.A. | Combination of a wee1 inhibitor and a topoisomerase 1 inhibitor |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002098370A2 (en) | 2001-03-02 | 2002-12-12 | Medimmune, Inc. | Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders |
| AR060635A1 (es) * | 2006-04-27 | 2008-07-02 | Banyu Pharma Co Ltd | Derivados de 1,2-dihidro-3h-pirazolo[3,4-d]pirimidin-3-ona, composiciones farmaceuticas que los comprenden y su uso en el tratamiento del cancer |
| CN104271576A (zh) * | 2012-02-23 | 2015-01-07 | 艾伯维公司 | 激酶的吡啶并嘧啶酮抑制剂 |
| GB201306610D0 (en) * | 2013-04-11 | 2013-05-29 | Almac Discovery Ltd | Pharmaceutical compounds |
| GB201612095D0 (en) * | 2016-07-12 | 2016-08-24 | Almac Discovery Ltd | Pharmaceutical compounds |
| CA3071405A1 (en) * | 2017-08-01 | 2019-02-07 | Recurium Ip Holdings, Llc | 1, 2 - dihydro- 3h- pyrazolo [3, 4 - d] pyrimidin -3 - one analogs |
| GB201800378D0 (en) * | 2018-01-10 | 2018-02-21 | Almac Discovery Ltd | Pharmaceutical compounds |
-
2022
- 2022-06-03 AU AU2022287033A patent/AU2022287033B2/en active Active
- 2022-06-03 KR KR1020247000364A patent/KR20240044409A/ko active Pending
- 2022-06-03 MX MX2023014466A patent/MX2023014466A/es unknown
- 2022-06-03 US US18/565,598 patent/US20240254123A1/en active Pending
- 2022-06-03 WO PCT/US2022/032203 patent/WO2022256680A1/en not_active Ceased
- 2022-06-03 CA CA3225152A patent/CA3225152A1/en active Pending
- 2022-06-03 JP JP2024518956A patent/JP2024522304A/ja active Pending
- 2022-06-03 CN CN202280054331.6A patent/CN117794932A/zh active Pending
- 2022-06-03 EP EP22735735.7A patent/EP4347592A1/en active Pending
- 2022-06-03 IL IL309037A patent/IL309037A/en unknown
-
2025
- 2025-06-23 AU AU2025204724A patent/AU2025204724A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL309037A (en) | Pyridopyrimidine derivatives are useful as WEE1 kinase inhibitors | |
| JP7014731B2 (ja) | 置換アミノプリン化合物、その組成物、及びそれらを用いた治療方法 | |
| CN120285177A (zh) | Hdac抑制剂和pd-1抑制剂的组合疗法 | |
| JP7611154B2 (ja) | ピリド－ピリミジニル化合物及び使用の方法 | |
| KR20190132687A (ko) | 항암 조합 요법 | |
| KR20130069603A (ko) | 종양 및 섬유증 질환 치료에서의 신규 병용 치료 | |
| JP2018534289A5 (https=) | ||
| JP2020515600A (ja) | 抗がん併用療法 | |
| RU2014142057A (ru) | Комплексная терапия | |
| CN112043702A (zh) | 用于联合治疗结直肠癌的喹啉类化合物 | |
| JP2025061387A (ja) | 複素環式タンパク質キナーゼ阻害剤を含む製剤 | |
| JP2024156732A (ja) | 抗腫瘍組成物 | |
| CN116323590A (zh) | 取代苯并或吡啶并嘧啶胺类抑制剂及其制备方法和应用 | |
| JP2022536655A (ja) | キナゾリニル化合物及び使用方法 | |
| KR20210136969A (ko) | 암의 치료 또는 예방에 사용하기 위한 퀴놀린 유도체 | |
| JPWO2022256680A5 (https=) | ||
| EP3125901B1 (en) | Derivatives of cephalosporin for treating cancer | |
| CN114340636A (zh) | 治疗方法 | |
| CN112043831A (zh) | 用于联合治疗乳腺癌的喹啉类化合物 | |
| JP7636322B2 (ja) | 癌を処置するためのマドラシン誘導体化合物、組成物およびこれらの使用 | |
| JP2019516728A (ja) | 抗がん組合せ治療 | |
| EP3310746A1 (en) | New crystalline polymorphs of 1,6-dibromo-1,6-dideoxy-dulcitol | |
| EP3973963A1 (en) | Quinoline derivatives for treatment of head and neck cancer | |
| JPWO2020095256A5 (https=) | ||
| CN116507331A (zh) | Tlr7/8拮抗剂及其用途 |